Back

Is the clinical benefit of primary prevention implantable cardioverter-defibrillator overestimated? The role of sudden cardiac death to total mortality ratio

European Heart Journal

30 September 2020
Organised by: Logo
Read full article
ESC Journals ARRHYTHMIAS AND DEVICE THERAPY HEART FAILURE Chronic Heart Failure Atrial Fibrillation (AF) IMAGING Cardiac Magnetic Resonance (CMR)
You may be interested in
thumbnail
Congress Session
Hot topics in the management of ventricular tachycardia and sudden cardiac death
1 April 2025
thumbnail
Congress Presentation
Risk factors for mortality within one-year after implantable cardioverter defibrillator implantation: a nationwide study
1 September 2020
thumbnail
Congress Presentation
Sudden cardiac death in a heart failure Mediterranean cohort. A perspective of 20 years
21 May 2022
thumbnail
Congress Presentation
Cost-effectiveness of implantable cardioverter defibrillator for the primary prevention of sudden death
1 July 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources